Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice (CROSBI ID 89808)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Petek, Marijan ; Sikirić, Predrag ; Anić, Tomislav ; Buljat, Gojko ; Šeparović, Jadranka ; Stančić-Rokotov, Dinko ; Seiwerth, Sven ; Grabarević, Željko ; Ručman, Rudolf ; Mikuš, Darko ; Zoričić, Ivan ; Prkačin, Ingrid ; Šebečić, Božidra ; Žiger, T. ; Čorić, Velimir ; Turković, Branko ; Aralica, Gorana ; Rotkvić, Ivo ; Miše, Stjepan ; Hahn, V.
engleski
Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice
A diabetogenic alloxan regimen produced lesions in all stomachs of treated animals, either rats (200 mg x kg(-1) s.c.) or mice (400 mg x kg(-1) i.p.). In control animals, the lesions, when developed (i.e. 24 h following application), appear to be quite sustained, and consistently present also after 1 or 2 weeks. The application of the pentadecapeptide BPC 157 (10 microg or 10 ng x kg(-1) i.p. coadministered together with alloxan) would significantly attenuate these lesions' appearance. This beneficial effect seems to be present in either rats or mice and in either of the tested intervals. Importantly, the beneficial effect seems to be shared by both microgram and nanogram regimens.
Pentadecapeptide BPC 157; Gastric lesions induced by alloxan; Alloxan; Rats; Mice
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Temeljne medicinske znanosti, Kliničke medicinske znanosti